Editor’s Choice of a new Journal; ‘Clinical Immunology, Endocrine & Metabolic Drugs’

9-19-2014 9-45-34 AM

Bentham Science Publishers is pleased to announce its new journal: ‘Clinical Immunology, Endocrine & Metabolic Drugs’

Editor-in-Chief: Emilio Jirillo (Professor of Immunology, University of Bari)

Editor’s Choice/Best Article:

“Androgen Receptor Antagonists in the Treatment of Prostate Cancer”

by Takashi Kawahara and Hiroshi Miyamoto

Read it here: http://bit.ly/1wrZp97

The Inaugural Issue is Open Access

click here: http://www.benthamscience.com/journal/contents.php?journalID=ciemd&issueID=123473

Recent Issues of Bentham Science Journals have been Published

Current Pharmaceutical Design, 20 Issue 36

Aims & scope

Current Pharmaceutical Design publishes timely in-depth reviews and research articles from leading pharmaceutical researchers in the field, covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area guest edited by an acknowledged authority in the field.

Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

http://www.eurekaselect.com/124509/issue/36

Abstracted & Indexed in

Biochemistry & Biophysics Citation Index®, BIOSIS, Chemical Abstracts, Current Contents®/Life Sciences, EMBASE/ExcerptaMedica, MEDLINE/Index Medicus, Medical Documentation Service®, Research Alert®, Science Citation Index®, Science Citation Index Expanded (SciSearch®), Cambridge Scientific Abstracts (CSA), PubsHub, Journal Citation Reports/Science Edition, Index to Scientific Reviews®, Custom Information Services®, BIOSIS Previews, BIOSIS Reviews Reports and Meetings, Scopus, GenamicsJournalSeek, and J-Gate.

For details about the latest issues, visit:http://benthamscience.com/journal/index.php?journalID=cpd

 

Current Medicinal Chemistry, 21 Issue 30

Aims & scope

Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews and guest edited thematic issues written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.

http://www.eurekaselect.com/124551/issue/30

Abstracted & Indexed in

Biochemistry and Biophysics Citation Index®, BIOSIS, Chemical Abstracts, Current Contents/Life Sciences, EMBASE/ExcerptaMedica, MEDLINE/Index Medicus, Reference Update, Research Alert, Science Citation Index®, Prous Science Integrity®, Science Citation Index Expanded, PubsHub, Journal Citation Reports/Science Edition, Index to Scientific Reviews®, BIOSIS Previews, BIOSIS Reviews Reports and Meetings, Scopus, EMBASE, BIOBASE, GenamicsJournalSeek, J-Gate, PubMed, and MediaFinder®-Standard Periodical Directory.

For details about the latest issues, visit:http://benthamscience.com/journal/index.php?journalID=cmc

 

Adolescent Psychiatry, 4 Issue 3

Aims & scope

Current Pharmaceutical Design publishes timely in-depth reviews and research articles from leading pharmaceutical researchers in the field, covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area guest edited by an acknowledged authority in the field.

Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

http://www.eurekaselect.com/124532/issue/3

Abstracted & Indexed in

Biochemistry & Biophysics Citation Index®, BIOSIS, Chemical Abstracts, Current Contents®/Life Sciences, EMBASE/ExcerptaMedica, MEDLINE/Index Medicus, Medical Documentation Service®, Research Alert®, Science Citation Index®, Science Citation Index Expanded (SciSearch®), Cambridge Scientific Abstracts (CSA), PubsHub, Journal Citation Reports/Science Edition, Index to Scientific Reviews®, Custom Information Services®, BIOSIS Previews, BIOSIS Reviews Reports and Meetings, Scopus, GenamicsJournalSeek, and J-Gate.

For details about the latest issues, visit: http://benthamscience.com/journal/index.php?journalID=aps

 

Nano science & Nanotechnology-Asia, 4 Issue 1

Aims & scope

Nanoscience& Nanotechnology-Asia publishes expert reviews, original research articles, letters and guest edited issues on all the most recent advances in nanoscience and nanotechnology with an emphasis on research in Asia and Japan. All aspects of the field are represented including chemistry, physics, materials science, biology and engineering mainly covering the following; synthesis, characterization, assembly, theory, and simulation of nanostructures (nanomaterials and assemblies, nanodevices, nano-bubbles, nano-droplets, nanofluidics, and self-assembled structures), nanofabrication, nanobiotechnology, nanomedicine and methods and tools for nanoscience and nanotechnology.

The Journal offers thorough and authoritative reviews, perspectives on cutting-edge research and discussions of topics that provide distinctive views about the future of nanoscience and nanotechnology.

http://www.eurekaselect.com/124528/issue/1

Abstracted & Indexed in

MediaFinder®-Standard Periodical Directory, Chemical Abstracts, J-Gate, and Scopus.

For details about the latest issues, visit: http://benthamscience.com/journal/index.php?journalID=nna

 

Current Pharmaceutical Design, 20 Issue 35

Aims & scope

Current Pharmaceutical Design publishes timely in-depth reviews and research articles from leading pharmaceutical researchers in the field, covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area guest edited by an acknowledged authority in the field.

Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

http://www.eurekaselect.com/124508/issue/35

Abstracted & Indexed in

Biochemistry & Biophysics Citation Index®, BIOSIS, Chemical Abstracts, Current Contents®/Life Sciences, EMBASE/ExcerptaMedica, MEDLINE/Index Medicus, Medical Documentation Service®, Research Alert®, Science Citation Index®, Science Citation Index Expanded (SciSearch®), Cambridge Scientific Abstracts (CSA), PubsHub, Journal Citation Reports/Science Edition, Index to Scientific Reviews®, Custom Information Services®, BIOSIS Previews, BIOSIS Reviews Reports and Meetings, Scopus, GenamicsJournalSeek, and J-Gate.

For details about the latest issues, visit: http://benthamscience.com/journal/index.php?journalID=cpd

 

Current Inorganic Chemistry, 4 Issue 1

Aims & scope

Current Inorganic Chemistry, a peer-reviewed journal, publishing original research, review articles and guest edited thematic issues in all areas of inorganic chemistry. The journal’s scope includes the synthesis, crystal structure, physical methods, thermodynamics, reactivity, spectroscopy, electronic and bonding properties of significant new and known (bio) inorganic and organometallic compounds.

Current Inorganic Chemistry is an important and reliable source of information on current developments, research and theory in the field. The emphasis is on publishing high quality articles.

http://www.eurekaselect.com/124511/issue/1

Abstracted & Indexed in

Chemical Abstracts, MediaFinder®-Standard Periodical Directory, and J-Gate.

For details about the latest issues, visit: http://benthamscience.com/journal/index.php?journalID=cic

Curtis & Coulter LLC Announce Upcoming Formulation Development & Bioequivalence Events

New York, NY, September 17, 2014 – Curtis & Coulter LLC, a new specialty life science events organizer is pleased to announce two new events specifically designed for pharmaceutical and biotech professionals. Taking place over the course of two days in November the events will be held at the Westin San Diego, CA.

TheBioequivalence: Intersection Between Science & Regulatory Summit and the Oral Drug Formulation Innovations Summitwere created to assist the life science industry with a simplified, compliant path for future drug approval and to accelerate drug product time-to-market.

“Given today’s current development challenges, there is a clear need for unified industrial collaboration in the fields of oral formulation development and bioequivalence testing.” stated Simon Curtis, Co-Founder& CEO of Curtis & Coulter LLC.“We are thrilled that multiple major industry players and global regulatory agencies share this vision, and are joining us this November for the benefit of the wider industry”.

November’s events will highlight key speakers from Pfizer, Merck, GlaxoSmithKline and Johnson & Johnson. Additionally presenters will include the FDA, and a number of other global regulatory agencies.

Registration is currently open for attendees for both November events. You can find out some more information by visitingwww.curtiscoulter.com

About Curtis & Coulter LLC

Curtis & Coulter specialize in researching and developing cutting-edge educational life science events designed to bring together industry professionals in a unique format for collaborative learning and networking. They provide an unmatched, innovative user experience to exchange ideas, gainadvanced industry knowledge and benchmark with like-minded peers through interactive platforms.

Media Contact:

Lauren Lorey

media@curtiscoulter.com

631-921-9175

Global Warming: Think Globally Act Locally, Save The Earth!

9-17-2014 10-55-45 AM

Global warming is the noticed century-scale rise in the average temperature of Earth’s climate system. Since 1971, 90% of the increased energy has been preserved in the oceans, mostly in the 0 to 700m region. Despite the oceans dominant role in energy storage, the term “global warming” is also used to mention to increases in average temperature of the air and sea at Earth’s surface. Since the early 20th century, the global air and sea surface temperature has increased about 0.8 °C, with about two-thirds of the expand occurring since 1980. Each of the last three decades has been successively warmer at the Earth’s surface than any preceding decade since 1850.

Scientific gripping of the cause of global warming has been increasing. In its fourth assessment of the relevant scientific literature, the Intergovernmental Panel on Climate Change reported that scientists were more than 90% certain that most of global warming was being caused by increasing concentrations of greenhouse gases manufactured by human activities. In 2010 that finding was acknowledged by the national science academies of all major industrialized nations.

The Earth’s average surface temperature rose over the period 1906–2005. The rate of warming over the last half of that period was almost doubles that for the period as a whole. The urban heat island effect is very small, estimated to account for less than 0.002 °C of warming per decade since 1900. Temperatures in the lower troposphere have increased between 0.13 and 0.22 °C per decade since 1979, according to satellite temperature measurements. Climate proxies show the temperature to have been relatively stable over the one or two thousand years before 1850, with regionally varying fluctuations such as the Medieval Warm Period and the little ice age.

Major article Contribution by some of the Chinese Authors in Bentham Science Publishers Journal; Current Nanoscience

Article Title: Preparation of D-tartaric Acid Modified Multi-walled Carbon Nanotubes for Resolution of Propranolol Enantiomers

Author(s): Dong-Ming Peng, Lin-Yan Yu, Jin-Gang Yu, Fei-Peng Jiao, Zhi-Guang Peng and Ting Zhang

Abstract:In this paper, multi-walled carbon nanotubes (MWCNTs) were oxidized by 30 w% hydrogen peroxide to introduce hydroxyl groups and carboxyl groups on it. Catalyzed by p-toluenesulfonic acid, D-tartaric acid (DTA) was grafted onto MWCNTs by an esterification reaction. Fourier transform infrared spectroscopy and high resolution transmission electron microscopy were used to elucidate the introduced groups and the morphologies changes of the MWCNTs samples. The D-tartaric acid modified MWCNTs were used as chiral im pregnating reagents for thin-layer chromatography for enantioseparation of propranolol enantiomers, and the chiral separation factor was achieved over 7.23 by a mixed solvent of acetonitrile-tert-butanol-acetic acid (volume ratio is 49:49:2) as developing solvent.

For more details, visit: http://benthamscience.com/journal/abstracts.php?journalID=cnano&articleID=114741

 

Article Title: Investigation on Interfacial Characteristics of W/Al Nanostructure

Author(s): Ping Yang, Dongjing Liu, Yunqing Tang, Jie Gong, Yu Liu and Haiying Yang

Abstract:The objective of this paper is to provide a systematic investigation on design or evaluation for W/Al interface structure in micro/ nano electronic manufacturing. To understand the basic mechanical properties of the W/Al interface structure, the elastic modulus and the hardness of the sample were investigated by nanoindentation. To investigate the integrating characteristics of the sample in progress, the effect of thermal loading and no-thermal loading on the integrating force of the W/Al interface is tested by nanoscratch. The interfacial bonding force between the films can be obtained for understanding the integrating characteristics. The results show that the interfacial bonding force can be improved by thermal loading, which means the mechanical properties of W/Al interface can be modulated and modified by using thermal loading. It is significant for design and industrial manufacturing process of W/Al interface structure.

Article Title: Highly Resolution of Propranolol Using Oxidized Multi-walled Carbon Nanotubes and β-cyclodextrin Derivatives as Impregnating Reagents
Author(s): Xiao-Qing Chen, Cong-Hao Sun, Fei-Peng Jiao, Jin-Gang Yu and Xin-Yu Jiang

Abstract: By using oxidized multi-walled carbon nanotubes and β-cyclodextrin derivatives (methyl-β-cyclodextrin or hydroxypropyl-β- cyclodextrin) as impregnating reagents, high efficiently resolution of (±)-propranolol, a kind of commonly used β-blockers, has been achieved on abovementioned reagents impregnated silica gel GF254 layers. The solvent system tert-butanol-acetonitrile with various volume ratios was further investigated. By detecting the spots at 254 nm with a UV lamp, the obtained chiral separation factors indicated oxidized multi-walled carbon nanotubes and β-cyclodextrin derivatives impregnated TLC plates could be used for effectively chiral recognition of racemic compounds.

For more details, visit: http://benthamscience.com/journal/abstracts.php?journalID=cnano&articleID=109011